Trial intelligence / Profile preview

Liuwei Dihuang Gantang Tablets for Menopausal Syndrome (Kidney Yin Deficiency)

CTR20222112Phase 3Completed

Sponsor
Institute of Toxicology and Pharmacology, Academy of Military Medical Sciences, People's Liberation Army of China
Start
Aug 2022
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of liuwei dihuang glycoside tablet in menopause, sponsored by Institute of Toxicology and Pharmacology, Academy of Military Medical Sciences, People's Liberation Army of China. Started Aug 2022; status: completed.

02

Drugs

liuwei dihuang glycoside tablet
03

Conditions

menopause

Beyond the preview

Go deeper on CTR20222112.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20222112.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call